相关实验视频
Updated: Jul 1, 2025

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.2K
在妇科癌症中优化息性盆腔放射治疗:系统性审查和分析
Beatrice Anghel1, Mihai-Teodor Georgescu2, Crenguta Sorina Serboiu3
1Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Diagnostics (Basel, Switzerland)
|March 13, 2024
概括
息性盆腔放射治疗有效地控制了妇科癌症 (GC) 的症状,特别是出血和疼痛. 需要进一步的研究来优化剂量和分量,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
- 妇科瘤学 妇科瘤学
背景情况:
- 息性放射治疗对于症状性妇科癌症 (GCs) 是至关重要的.
- 对宫癌,子宫内膜癌,卵巢癌,阴道癌和癌的息性盆腔放射疗法的系统审查.
- 关注症状缓解,生活质量 (QOL) 和毒性.
研究的目的:
- 系统地审查有关息性盆腔放射治疗的文献.
- 评估症状缓解,QOL和毒性.
- 确定最佳的放射治疗方案.
主要方法:
- 在Medline搜索到2023年11月之前发表的论文.
- 选择详细介绍症状和QOL的研究,用于GCs的息性盆腔放射治疗.
主要成果:
- 审查了31项研究,其中许多是回顾性的,结果各不相同.
- 有效管理出血 (55%) 和控制疼痛 (70%).
- 10 Gy 分割对女性生殖道癌症的出血和疼痛有好处.
结论:
- 息性盆腔放射治疗对于症状性GCs是有效的.
- 剂量和分化需要进一步调查.
- 将现代疗法与放射治疗结合起来,可以改善选择患者的症状控制.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345

